CTOs on the Move


 
AllMed Healthcare Management is a utilization management and independent review organization providing comprehensive nurse and physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed`s state-of-the-art medical review portal.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.allmedmd.com
  • 111 SouthWest Fifth Avenue Suite 1400
    Portland, OR USA 97204
  • Phone: 800.400.9916

Executives

Name Title Contact Details
Jeff Keating
Chief Technology Officer Profile

Similar Companies

BMR HealthQuest

BMR HealthQuest is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioscan, Inc.

Bioscan, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Washington, DC. To find more information about Bioscan, Inc., please visit www.bioscan.com

Cypress County - Family and Community Support Services

Cypress County - Family and Community Support Services is a Fort Mcmurray, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care 2000 Home HealthCare Services

Care 2000 Home HealthCare Services, LLC is a Fergus Falls, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.